SCHEMBL7571007

SCHEMBL7571007

CC(C)c1ccccc1-c1cc(C=O)ccc1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 1/20 0.37
USP7 Q93009 1/20 0.37
AR P10275 1/20 0.37
TYR P14679 1/20 0.35
PDE10A Q9Y233 1/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
IMPDH2 P12268 1/20 0.33
IMPDH1 P20839 1/20 0.33
KIF11 P52732 2/20 0.33
KDM4E B2RXH2 1/20 0.32
GALR3 O60755 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
MAOA P21397 1/20 0.32
USP1 O94782 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570617 0.81 AR (0.44) USP8USP7ARKDM4EGALR3
SCHEMBL13570798 0.80 TYR (0.42) ARTYRIMPDH2IMPDH1KDM4E
SCHEMBL7575302 0.78 AR (0.38) USP8USP7ARPDE10AKIF11
SCHEMBL7577589 0.78 KDM4E (0.43) USP8USP7ARKDM4EGALR3
SCHEMBL7577326 0.77 AR (0.48) ARIMPDH2IMPDH1KDM4EALDH1A1
SCHEMBL7576912 0.75 MCL1 (0.47) CA1CA2KIF11KDM4EALDH1A1
SCHEMBL7571276 0.75 TSHR (0.37) USP8USP7ARKDM4EGALR3
SCHEMBL7571095 0.75 ALDH1A1 (0.46) KIF11KDM4EGALR3ALDH1A1GAA
SCHEMBL7569928 0.74 GABRA1 (0.38) USP8USP7ARPDE10AUSP1
SCHEMBL7577096 0.73 SLC22A12 (0.37) USP8USP7CA1CA2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 USP8 3536/4885USP7 3833/4885AR 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.